Fig. 2From: Factors affecting serum phenobarbital concentration changes in pediatric patients receiving elixir and powder formulationsDifference in the weight-corrected PB C/D ratio between groups. (A) Effect of the concomitant use of the interacting drugs (VPA or amiodarone), (B) Effect of administration route and dosage formulationBack to article page